Cardinal Health sees healthy demand, despite modest commodity pressure
Cardinal Health Inc. shares jumped on Thursday after the company reported better-than-expected first-quarter 2027 earnings ...
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Our AI scores Cardinal Health Inc every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Cardinal Health Inc is a large-cap company with a market capitalization of $63.20B. It ranks number 3 by market capitalization among the 7 Wholesale-Drugs, Proprietaries & Druggists' Sundries issuers in our coverage with a current forecast.
For CAH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 24.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 3.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CAH included.
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Wholesale-Drugs, Proprietaries & Druggists' Sundries peers listed below that report each metric.
| Metric | CAH | Rank |
|---|---|---|
| Market Cap | $63.20B | 3/7 |
| P/E Ratio | 28.27x | – |
| EPS | $9.61 | – |
| Metric | CAH | Rank |
|---|---|---|
| Gross Margin | 2.8% | 7/7 |
| Operating Margin | 0.8% | 4/6 |
| Net Margin | 0.7% | 4/7 |
| EBT Margin | 0.7% | 4/7 |
| Tax Rate | 21.0% | – |
| Metric | CAH | Rank |
|---|---|---|
| Current Ratio | 0.88x | 7/7 |
| Quick Ratio | 0.49x | 7/7 |
| Interest Coverage | 10.3x | 1/6 |
| Working Capital | -$5.34B | 6/7 |
| Metric | CAH | Rank |
|---|---|---|
| Operating Cash Flow | $6.57B | 2/7 |
| OCF Growth YoY | 174.2% | 2/5 |
| Metric | CAH | Rank |
|---|---|---|
| Inventory Turnover | 16.8x | 2/7 |
| Days Inventory | 22 days | 6/7 |
| Payables Period | 48 days | 4/6 |
| Metric | CAH | Rank |
|---|---|---|
| Operating Income | $3.37B | 2/6 |
| Net Income | $2.86B | 2/7 |
| SG&A Expense | $7.73B | 2/6 |
| Cost of Goods Sold | $309.39B | 3/7 |
| Metric | CAH | Rank |
|---|---|---|
| Shares Outstanding | 233M | – |
| Net Income Growth | 79.2% | 1/5 |
| EPS Growth | 49.0% | 1/5 |
| Total Current Assets | $40.99B | 71.5% of assets |
| Cash & Short-term Investments | $5.26B | 9.2% of assets |
| Accounts Receivable | $14.54B | 25.4% of assets |
| Inventory | $18.39B | 32.1% of assets |
| Total Liabilities | $60.02B | |
| Short-term Debt | $5.39B | 9.4% of assets |
Companies classified under the same SEC industry code as Cardinal Health Inc (Wholesale-Drugs, Proprietaries & Druggists' Sundries): 7 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeCardinal Health Inc. shares jumped on Thursday after the company reported better-than-expected first-quarter 2027 earnings ...
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 4.5% on Thursday. The Dow traded ...
All right. Good morning, everyone. Welcome to day 2 of the Citi Global Healthcare Conference. Really pleased to have with us today this morning, Cardinal Health, Aaron Alt, the CFO of Cardinal Health; ...
Our AI scores Cardinal Health Inc every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
For CAH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 24.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 3.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Cardinal Health Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
7 issuers in our coverage, CAH included, share the SEC industry code Wholesale-Drugs, Proprietaries & Druggists' Sundries. The largest are: Mckesson Corp (MCK), Cencora, Inc. (COR), Herbalife Ltd. (HLF), Nu Skin Enterprises, Inc. (NUS), Enersyn Global Inc. (ESYN), Cosmos Health Inc. (COSM).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.